World Health Organization (WHO) to hold consultation on report of Expert Working Group on R&D financing

At the end of a dramatic debate that began yesterday, the Executive Board (EB) of the World Health Organization (WHO) agreed to hold a special consultation on the report of the WHO Expert Working Group (EWG) on R&D Financing. A face-to-face meeting will be held on May 13, a few days before the 63rd WHA begins on 17 May. There will also be opportunities for web submissions on the EWG report. In addition, Dr. Continue Reading

Uncategorized

Open Letter to the WHO EB from Cecilia López Montaño, EWG member

The following is a letter sent by Cecilia López Montaño, a member of the WHO Expert Working Group on R&D Financing to the WHO Executive Board:

Bogotá. Colombia. January 15th 2010

Dear members of the Executive Board:

I am Cecilia López Montaño, senator of the Colombian Congress and member of the Expert Working Group on Research and Development Financing of the World Health Organization, in representation of the point of view of developing countries, I assume.

Continue Reading

Uncategorized

Final Report of the WHO Expert Working on R&D Financing published on Friday, January 15, 2010

At the proverbial 11th hour today, the World Health Organization published the final report of the “World Health Organization Expert Working Group on Research and Development Financing” in English three days before the commencement of the 126th session of the WHO Executive Board on January 18, 2010. At this juncture, it does not appear that the WHO Secretariat has made available official versions of this Report in Arabic, Chinese, French, Russian and Spanish for Member States’ consideration.

Continue Reading

Uncategorized

A closer look at the WHO EWG endorsed proposals on funding product development partnerships

The World Health Organization’s Expert Working Group on R&D Financing spent scant attention on how to raise money, but showed considerable interest in how to spend it. The clear favorite approach is to give grants to product development partnerships — the approach that has now become the most conventional approach, and one not surprisingly endorsed by the PDPs themselves, and also by the Gates Foundation and the IFPMA — two groups that are often seen as devoted to protecting the status quo in terms of intellectual property and business models for innovation.

Continue Reading

Uncategorized
1

The baffling WHO EWG analysis of innovation inducement prizes

The World Health Organization (WHO) Executive Board will soon consider the Executive Summary of the Report of the Expert Working Group on Research and Development Financing, a document, formally identified as EB 126/6 Add.1.

In the section of the report on “Funding allocation proposals,” the EWG considers two types of innovation inducement prizes, including

31 (c) milestone prizes; and
31 (d) end-prizes (cash)

Continue Reading

New WHO documents published in relation to 3rd EWG meeting

New documents have been published on the WHO website in relation to the third meeting of the WHO Expert Working Group on R&D Financing that took place from November 30 to December 2, 2009. These six documents are available at:

http://www.who.int/phi/ewg3rdmeet/en/index.html

The first document is: Comparative Review of Innovative Financing Proposals for Health R&D

The second document is: Coordinating Arrangements for R&D [doc 352kb]

Continue Reading

Uncategorized